Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
359K
-
Shares change
-
-35.5K
-
Total reported value, excl. options
-
$18.1M
-
Value change
-
-$1.8M
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$50.59
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2023
6 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2023.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 359K shares
of 159M outstanding shares and own 0.23% of the company stock.
Largest 10 shareholders include FMR LLC (21.5M shares), VANGUARD GROUP INC (14.2M shares), T. Rowe Price Investment Management, Inc. (13.2M shares), BlackRock Inc. (9.06M shares), Bellevue Group AG (8.71M shares), Clearbridge Investments, LLC (4.71M shares), WELLINGTON MANAGEMENT GROUP LLP (4.62M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.26M shares), STATE STREET CORP (4.01M shares), and Pictet Asset Management Holding SA (3.52M shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.